Marquette Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.31K Sell
90
-46
-34% -$4.11K ﹤0.01% 324
2026
Q1
$9.77K Sell
136
-1
-0.7% -$77 ﹤0.01% 258
2025
Q4
$10.9K Buy
137
+27
+25% +$2.13K ﹤0.01% 222
2025
Q3
$8.29K Buy
+110
New +$7.54K ﹤0.01% 240
2024
Q4
Sell
-3,630
Closed -$228K 196
2024
Q3
$228K Buy
+3,630
New +$212K 0.04% 93
2023
Q1
Sell
-335
Closed -$31.2K 217
2022
Q4
$31.2K Hold
335
0.01% 165
2022
Q3
$32K Sell
335
-7
-2% -$693 0.01% 158
2022
Q2
$32K Sell
342
-218
-39% -$21.3K 0.01% 182
2022
Q1
$57K Hold
560
0.01% 182
2021
Q4
$58K Hold
560
0.01% 178
2021
Q3
$48K Hold
560
0.01% 182
2021
Q2
$47K Hold
560
0.01% 172
2021
Q1
$42K Hold
560
0.01% 169
2020
Q4
$38K Hold
560
0.01% 172
2020
Q3
$33K Hold
560
0.01% 159
2020
Q2
$36K Hold
560
0.01% 169
2020
Q1
$33K Buy
560
+335
+149% +$22.4K 0.01% 172
2019
Q4
$17K Hold
225
0.01% 193
2019
Q3
$14K Buy
+225
New +$13.3K ﹤0.01% 226

Other funds holding CVS

Marquette Asset Management's CVS Position: Q2 2026 in Review

Marquette Asset Management reduced its CVS Health (CVS) stake by 34% in Q2 2026, selling an estimated $4.11K and leaving 90 shares worth $9.31K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

Marquette Asset Management first reported a position in CVS in Q3 2019 and has held it in 19 quarters since. The position peaked at $228K in Q3 2024. 862 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Marquette Asset Management held 90 shares of CVS Health worth $9.31K as of Q2 2026.
  • Marquette Asset Management sold 46 CVS Health shares in Q2 2026, an estimated $4.11K.
  • CVS Health made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #324 holding.
  • Marquette Asset Management first reported a position in CVS Health in Q3 2019 and has held it in 19 quarters since.
  • Marquette Asset Management's CVS Health position peaked at $228K in Q3 2024.
  • 862 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.